I'm sure the economic boffins in Senex have done their NPV calcs that spending $40 mil, more then makes up for the delay in any extra divvies you get short term.
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%